Tag: ANA research countries

OTC transactions are one of the most contentious issues in digital financial services (DFS). Some argue that OTC can decrease provider profitability, stymie product evolution, and can lead to unregistered transactions increasing the risk to terrorism financing and money laundering.This blog seeks to demystify one of the five concerns by analysing evidence from ANA research countries: OTC can prevent product evolution.